WuXi AppTec(2359.HK)
Focus: WuXi AppTec is a 50,000+ employee CDMO (Contract Development and Manufacturing Organization) headquartered in Shanghai, China, serving as a critical outsourcing partner for global pharmaceutical and biotech companies. The company is publicly listed on the Hong Kong Stock Exchange (ticker: 2359.HK) and operates at significant scale in drug development and manufacturing services.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
50000+
Open Jobs
0
About WuXi AppTec
AI assessmentNot HiringNo open roles listed right now. Follow WuXi AppTec to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for WuXi AppTec
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.